Contour ProtegeAI is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: MIM Software. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Ibex Galen Platform is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
InferCare RECIST is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Beijing Infervision Medical Technology. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Kheiron Mia is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Lunit INSIGHT DBT V1.2 is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Lunit. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Median LCS / eyonis LCS is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Median Technologies. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Mindpeak Breast AI is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Owkin K1 is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Paige Prostate Suite is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
PathAI AISight is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Quibim QP Platform is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Therapixel MammoScreen is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
HealthAIdir